Astrana Health Inc (ASTH)vsDaVita HealthCare Partners Inc (DVA)
ASTH
Astrana Health Inc
$24.48
+1.92%
HEALTHCARE · Cap: $1.36B
DVA
DaVita HealthCare Partners Inc
$155.11
+1.19%
HEALTHCARE · Cap: $10.25B
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 329% more annual revenue ($13.64B vs $3.18B). ASTH leads profitability with a 71.0% profit margin vs 5.5%. DVA trades at a lower P/E of 16.1x. DVA earns a higher WallStSmart Score of 66/100 (B-).
ASTH
Hold46
out of 100
Grade: D+
DVA
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-508.0%
Fair Value
$3.13
Current Price
$24.48
$21.35 premium
Margin of Safety
+11.7%
Fair Value
$163.40
Current Price
$155.11
$8.29 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 71 of every $100 in revenue as profit
Revenue surging 42.9% year-over-year
Reasonable price relative to book value
Every $100 of equity generates 65 in profit
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
Smaller company, higher risk/reward
ROE of 4.5% — below average capital efficiency
Operating margin of 1.9%
Premium valuation, high expectations priced in
5.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Profit Margin, Revenue Growth, Price/Book. Profitability is solid with margins at 71.0% and operating margin at 1.9%. Revenue growth of 42.9% demonstrates continued momentum.
Bull Case : DVA
The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Operating Margin. A P/E of 53.2x leaves little room for execution misses.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Key Dynamics to Monitor
ASTH profiles as a growth stock while DVA is a value play — different risk/reward profiles.
DVA carries more volatility with a beta of 0.93 — expect wider price swings.
ASTH is growing revenue faster at 42.9% — sustainability is the question.
DVA generates stronger free cash flow (395M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (66/100 vs 46/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?